Preview record
Ipamorelin 5 mg
Research reagent · 5 mg
A synthetic GHS-class pentapeptide in lyophilised laboratory format, 5 mg per vial (declared).
The price is provisional. Ordering is not open yet — contact us and we will let you know when sales start.
Tell me when sales open01 / About the material
Description
Ipamorelin is a synthetic peptide of five amino-acid residues, described in 1998 as the first selective growth hormone secretagogue. The material is intended for laboratory research.
Batch analytical documentation is published after review. Identity, purity, and quantity are confirmed by separate methods and never substitute for one another.
Research context
Ipamorelin's foundational characterisation was published in the European Journal of Endocrinology (1998): selective GH-release stimulation without material effects on cortisol or ACTH in experimental models. Clinical development was never completed. See "What is Ipamorelin?" for details.
- What is Ipamorelin?
- What makes Ipamorelin "selective"?
- CJC-1295 and Ipamorelin: why does one name never travel without the other?
For laboratory and research purposes. Not intended for human use.
03 / FAQ
Frequent questions
- What is this material intended for?
- Strictly for laboratory research purposes. The material is not intended for human use and is not a medicine.
- Where is the batch documentation?
- Analytical documents appear on the page once their link to a specific batch is verified. Until then the documentation status honestly reads "pending review".
- When will ordering open?
- Ordering opens once catalogue verification, payment, and delivery are activated. Contact us and we will let you know when sales start.
04 / Catalogue
